| Year |
Citation |
Score |
| 2021 |
Cho BS, Yahng SA, Min GJ, Park S, Park SS, Shin SH, Jeon YW, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients. Transplantation and Cellular Therapy. PMID 34082159 DOI: 10.1016/j.jtct.2021.05.024 |
0.306 |
|
| 2020 |
Cho BS, Min GJ, Park S, Park SS, Shin SH, Yahng SA, Jeon YW, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Haploidentical versus matched unrelated donor transplantation for acute myeloid leukemia in remission: a prospective comparative study. American Journal of Hematology. PMID 32905642 DOI: 10.1002/ajh.25993 |
0.317 |
|
| 2020 |
Park S, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, et al. Comparison of myeloablative (CyTBI, BuCy) versus reduced-intensity (FluBu2TBI400) peripheral blood stem cell transplantation in acute myeloid leukemia patients with pre-transplant low WT1 expression. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32659434 DOI: 10.1016/j.bbmt.2020.07.006 |
0.311 |
|
| 2020 |
Yoon JH, Park SS, Min GJ, Park S, Lee SE, Cho BS, Kim YJ, Lee S, Kim HJ, Min CK, Cho SG, Lee JW, Eom KS. Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis: case series with a patient presenting with extensive extramedullary hematopoiesis. Therapeutic Advances in Hematology. 11: 2040620720932038. PMID 32655847 DOI: 10.1177/2040620720932038 |
0.308 |
|
| 2020 |
Lee SE, Min GJ, Park SS, Park S, Yoon JH, Shin SH, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Lee JW. Outcomes of haploidentical stem cell transplantation using total body irradiation (600 cGy) and fludarabine with ATG in adult patients with severe aplastic anemia: A prospective phase II study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32634577 DOI: 10.1016/j.bbmt.2020.06.024 |
0.313 |
|
| 2019 |
Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma. Annals of Hematology. PMID 31089793 DOI: 10.1007/s00277-019-03714-x |
0.311 |
|
| 2019 |
Cho BS, Jeon YW, Hahn AR, Lee TH, Park SS, Yoon JH, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Min WS, Kim HJ. Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia. Cancer Medicine. PMID 30677244 DOI: 10.1002/cam4.1928 |
0.318 |
|
| 2019 |
Shin JY, Park S, Min GJ, Park S, Lee S, Yoon J, Shin S, Lee S, Eom K, Kim Y, Lee S, Min C, Kim H, Cho S, Lee J. Comparable Outcomes between Unrelated Donor (8/8 or 7/8 matched) and Haploidentical Donor for Allogeneic Stem Cell Transplantation in Adult Patients with Severe Aplastic Anemia Blood. 134: 4619-4619. DOI: 10.1182/blood-2019-130419 |
0.312 |
|
| 2019 |
Park S, MIN GJ, Park S, Yahng S, Jeon Y, Shin S, Yoon J, Lee S, Cho B, Eom K, Kim Y, Lee S, Min CK, Cho S, Kim D, et al. Comparison of Myeloablative (CyTBI, BuCy) Versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Low WT1 Expression Level at Transplant Blood. 134: 1973-1973. DOI: 10.1182/blood-2019-128306 |
0.317 |
|
| 2018 |
Yahng SA, Park SS, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, et al. Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia. Bone Marrow Transplantation. PMID 29563590 DOI: 10.1038/s41409-018-0154-0 |
0.303 |
|
| 2016 |
Yahng SA, Kim M, Kim TM, Jeon YW, Yoon JH, Shin SH, Lee SE, Eom KS, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Kim YJ. Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts. Oncotarget. PMID 27729615 DOI: 10.18632/oncotarget.12511 |
0.315 |
|
| 2016 |
Yoon JH, Lee S, Kim HJ, Jeon YW, Lee SE, Cho BS, Lee DG, Eom KS, Kim YJ, Min CK, Cho SG, Min WS, Lee JW. Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission. Oncotarget. PMID 26883100 DOI: 10.18632/oncotarget.7347 |
0.306 |
|
| 2016 |
Yoon J, Park S, Jeon Y, Lee S, Cho B, Eom K, Kim Y, Kim H, Min C, Cho S, Kim D, Lee JW, Min W, Lee S. Comparable Long-Term Outcomes of Reduced-Intensity and Myeloablative Conditioning Allogeneic Hematopoietic Cell Transplantation By Minimal Residual Disease Kinetics during the Tyrosine Kinase Inhibitor-Based Chemotherapy Courses in Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia in First Remission Blood. 128: 3979-3979. DOI: 10.1182/blood.v128.22.3979.3979 |
0.31 |
|
| 2015 |
Lee SE, Kim JH, Jeon YW, Yoon JH, Shin SH, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Lee JW, Min WS, Park CW, Min CK. Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma. Annals of Hematology. 94: 445-52. PMID 25257340 DOI: 10.1007/s00277-014-2216-8 |
0.309 |
|
| 2013 |
Yoon JH, Kim HJ, Shin SH, Yahng SA, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation. International Journal of Hematology. 97: 773-81. PMID 23616221 DOI: 10.1007/s12185-013-1335-7 |
0.309 |
|
| 2013 |
Lee SE, Yoon JH, Shin SH, Yahng SA, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim M, et al. Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia. International Journal of Hematology. 97: 640-9. PMID 23529846 DOI: 10.1007/s12185-013-1312-1 |
0.313 |
|
| 2013 |
Yoon J, Lee S, Kim H, Kim J, Jeon Y, Shin S, Lee S, Eom K, Kim Y, Min C, Cho S, Kim D, Min W, Park C, Lee J. Impact Of CMV Reactivation On Relapse In Patients With Acute Leukemia Who Received Allogeneic Stem Cell Transplantation In First Remission: Possible GVL Effect In CMV Seropositive Population Blood. 122: 3345-3345. DOI: 10.1182/blood.v122.21.3345.3345 |
0.307 |
|
| 2012 |
Cho BS, Yoon JH, Shin SH, Yahng SA, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ. Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1552-63. PMID 22516055 DOI: 10.1016/j.bbmt.2012.04.008 |
0.315 |
|
| 2011 |
Lee JW, Cho BS, Lee SE, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Min WS, Park CW. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 101-8. PMID 20601037 DOI: 10.1016/j.bbmt.2010.06.014 |
0.313 |
|
| 2011 |
Yahng S, Kim Y, Yoon J, Shin S, Lee S, Cho B, Eom K, Lee S, Min C, Kim H, Cho S, Kim D, Lee J, Min W, Park C. Response to Pre-Grafting Hypomethylating Treatment Predicts Transplant Outcomes of MDS Blood. 118: 2034-2034. DOI: 10.1182/blood.v118.21.2034.2034 |
0.323 |
|
| 2010 |
Eom K, Kim H, Cho B, Lee S, Yahng S, Kim Y, Lee S, Min C, Cho S, Kim D, Lee J, Park C, Min W. Outcomes of a Prospective Phase II Study of Reduced-Intensity Stem Cell Transplantation for Acute Myeloid Leukemia with t(8;21)- In Comparison with Autologous and Myeloablative Allogeneic Stem Cell Transplantation. Blood. 116: 4559-4559. DOI: 10.1182/blood.v116.21.4559.4559 |
0.306 |
|
| 2010 |
Lee S, Cho B, Yahng S, Eom K, Kim Y, Kim H, Lee S, Min C, Cho S, Kim D, Lee J, Min W, Park C. Graft-Versus-Tumor Effect In Patients with Graft-Versus-Host Disease Defined by NIH Consensus Criteria Blood. 116: 2343-2343. DOI: 10.1182/blood.v116.21.2343.2343 |
0.303 |
|
| 2010 |
Lee S, Kim H, Min W, Yahng S, Cho B, Eom K, Kim Y, Min C, Lee S, Cho S, Kim D, Lee J, Park C. The Cutoff Leukemic Cell Burden to Influence Outcomes of Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia In Hematological Complete Remission. Blood. 116: 1298-1298. DOI: 10.1182/blood.v116.21.1298.1298 |
0.317 |
|
| 2009 |
Eun Lee S, Kim YJ, Cho SG, Cho BS, Eom K, Kim HJ, Lee S, Min C, Kim DW, Lee JW, Min WS, Park CW, Kim CC. Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome with a Reduced Intensity Conditioning Regimen Consisting of Intravenous Busulfan, Fludarabine, and 400 Cgy Total Body Irradiation. Blood. 114: 4327-4327. DOI: 10.1182/blood.v114.22.4327.4327 |
0.305 |
|
| 2007 |
Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 1083-94. PMID 17697971 DOI: 10.1016/j.bbmt.2007.06.001 |
0.308 |
|
| 2007 |
Cho BS, Kim YJ, Cho SG, Kim SY, Eom KS, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Kim CC. The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome. International Journal of Hematology. 85: 446-55. PMID 17562624 DOI: 10.1532/IJH97.A30616 |
0.318 |
|
| 2007 |
Cho B, Kim S, Kim Y, Eom K, Kim H, Lee S, Min C, Kim D, Lee J, Min W, Kim C. Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34+-Enriched PBSC in Combination with BM. Blood. 110: 1111-1111. DOI: 10.1182/blood.v110.11.1111.1111 |
0.307 |
|
| 2006 |
Eom KS, Min CK, Lee S, Kim YJ, Kim SY, Kim HJ, Lee JW, Min WS, Kim CC. Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma Japanese Journal of Clinical Oncology. 36: 432-438. PMID 16782727 DOI: 10.1093/jjco/hyl041 |
0.306 |
|
| 2006 |
Lee S, Cho B, Kim S, Eom K, Kim Y, Min C, Kim H, Cho S, Kim D, Lee J, Min W, Park J, Kim C. Allogeneic Stem Cell Transplantation Should Be Performed in First Complete Remission in Adults with Acute Lymphoblastic Leukemia; Strong Antileukemic Activity of Chronic Graft-Versus-Host Disease. Blood. 108: 2992-2992. DOI: 10.1182/blood.v108.11.2992.2992 |
0.31 |
|
| Show low-probability matches. |